GILEAD SCIENCES, INC.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
GILD$170.87+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2025 | 2024 | 2023 |
| Net income | $8,510 | $480 | $5,613 |
| Other comprehensive (loss) income, net of reclassifications and taxes: | |||
| Net gain (loss) on foreign currency translation | 38 | (26) | 60 |
| Net gain on available-for-sale debt securities | 8 | 5 | 28 |
| Net (loss) gain on cash flow hedges | (139) | 125 | (62) |
| Other comprehensive (loss) income, net | (93) | 104 | 26 |
| Comprehensive income, net | 8,418 | 584 | 5,639 |
| Comprehensive loss attributable to noncontrolling interest, net | — | — | (52) |
| Comprehensive income attributable to Gilead, net | $8,418 | $584 | $5,691 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.